Bazlitoran sodiumProduct ingredient for Bazlitoran
- Name
- Bazlitoran sodium
- Drug Entry
- Bazlitoran
Bazlitoran is under investigation in clinical trial NCT02092909 (Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia).
- Accession Number
- DBSALT003406
- Structure
- Synonyms
- ALL-P-AMBO-2'-DEOXY-P-THIOCYTIDYLYL-(3'->5')-P-THIOTHYMIDYLYL-(3'->5')-2'-DEOXY-P-THIOADENYLYL-(3'->5')-P-THIOTHYMIDYLYL-(3'->5')-2'-DEOXY-P-THIOCYTIDYLYL-(3'->5')-P-THIOTHYMIDYLYL-(3'->5')-2'-O-METHYL-P-THIOGUANYLYL-(3'->5')-2'-O-METHYL-P-THIOURIDYLYL-( / DNA, (P-THIO)(C-T-A-T-C-T-RGM-RUM-M5C-C7G-T-T-C-T-C-T-RGM-RUM), SODIUM SALT (1:17) / IMO-8400 SODIUM
- UNII
- 1NLR4WAG4U
- CAS Number
- 1613607-40-1
- External Links
- Not Available
- Predicted Properties
- Not Available
